LifePoint Health got the important first-quarter earnings season off to a rocky start Friday, posting a decline in earnings per share and leading hospital stocks to a down day on Wall Street. The system's shares never recovered from an early sell-off after the company announced Friday morning a...
Top officials at Wayne State University and Detroit Medical Center have agreed to a new negotiating plan to move contract talks forward, Crain's Detroit Business has learned.
Biotech billionaire Dr. Patrick Soon-Shiong, 63, topped Bloomberg's Pay Index for 2015, beating out others by more than $170 million.
Stanmore Implants Worldwide designs and manufactures implant systems used primarily in limb salvage for adult and juvenile oncology patients.
Petaluma Valley Hospital in California's Sonoma County this week suspended talks with Prime Healthcare Services as it attempts to solidify a deal with first-choice buyer St. Joseph Health.
Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report for 2015 on Friday. The badly tarnished Canadian drugmaker also announced a slate of mostly new nominees for elections to its board in June.
The Federal Reserve did its part this week to boost hospital stocks by again not raising interest rates. Now the investor-owned hospital companies will have to prove with their earnings whether it's safe for investors to give them another look.
Gilead Sciences' earnings tumbled more than 17% in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.
Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.
SSM Health, a large Catholic hospital system, has fully divested its investments in companies that produce coal. It joins a growing coalition of healthcare organizations that view climate change as an immediate threat to public health.
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical-device maker's share of the market for cardiovascular care.
A federal jury recently awarded a former healthcare staffing company co-owner $27.6 million in a lawsuit that included allegations of fraud, violence, abuse and rumors.